세계의 일회용 내시경 시장 : 디바이스 유형별, 용도별, 최종사용자별, 지역별, 기회 및 예측(2018-2032년)

Global disposable endoscopes market is projected to witness a CAGR of 11.89% during the forecast period 2025-2032, growing from USD 2.45 billion in 2024 to USD 6.02 billion in 2032. The market's growth is supported by the increasing awareness about the various advantages associated with disposable endoscopes such as economic efficiency, reduced risk of device-related infections, rising cases of colorectal cancer, and increasing investments in product innovations and technological advancements. As per the estimates of the World Health Organization (WHO) colorectal cancer accounts for approximately 10% of all cancer cases across the globe.

Traditional reusable endoscopes, despite rigorous reprocessing protocols, pose a substantial infection risk due to their complex structure and difficulty in achieving full sterilization and have been linked to serious outbreaks of infections, prompting stringent hospital audits. Disposable endoscopes offer an effective alternative by removing the requirement for disinfection between patients and ensuring the availability of a sterile device for each use, making them suitable for high-risk environments including emergency rooms and ICUs. Regulatory bodies across the globe are issuing alerts regarding infection risks associated with bronchoscopes, creating a strong push for disposable alternatives. The adoption of disposable endoscopes is also increasing among outpatient clinics and ambulatory surgical centers due to their ease of use and economically efficient nature.

Increasing Prevalence of Gastrointestinal Disorders Boosts Market Demand

The rising cases of gastrointestinal disorders (such as stomach cancer, irritable bowel syndrome, and functional constipation) due to the rapid expansion of the aging population, increasing urbanization, and changing eating habits and sedentary lifestyle are propelling the requirement for different diagnostic procedures such as endoscopy. As per the estimates of the American Cancer Society, around 30,300 new cases of stomach cancer will be reported in the United States in 2025. Medical professionals across the globe are adopting disposable endoscopes as they offer a wide range of advantages including immediate availability for urgent procedures, reduced risk of infection, and elimination of reprocessing. The shift towards disposable endoscopes can also address concerns related to infection control while meeting the rising demand for high quality therapeutic and diagnostic interventions, thus fueling the market's growth. Thus, healthcare systems are increasingly relying upon disposable endoscopes for managing high volumes of gastrointestinal cases in a safe and efficient manner.

Technological Innovations Support Market Expansion

Innovations in material science and digital integration are allowing the availability of novel devices and technologies and supporting the expansion of the disposable endoscopes market. Increasing investments in novel product launches and product innovations are also propelling the availability of advanced solutions that increase the convenience of medical professionals. For instance, in April 2024, Ambu A/S received 510(k) regulatory clearance from the United States Food and Drug Administration (US FDA) for Ambu aBox 2 and Ambu aScope Gastro Large. This clearance ensures the provision of extended solution offering for gastroenterologists and surgeons performing procedures in the upper portion of the gastrointestinal tract. Moreover, by reducing the risk of infection and eliminating the requirement for reprocessing, Ambu's products improve patient safety and workflow efficiency, allowing it to expand its presence in the industry and support the market's expansion. Furthermore, various companies are also working on innovations to improve the cost effectiveness of disposable endoscopes to support their adoption in economically weaker regions.

Bronchoscopy Accounts for Significant Share of the Market

The increasing adoption of disposable bronchoscopes can be attributed to their role in diagnosis of pulmonary diseases, utility in airway management, and increasing cases of infectious diseases. With the rising cases of chronic respiratory diseases and lung cancer across the globe, the number of bronchoscopic interventions are increasing, supporting the segment's dominance. Additionally, disposable bronchoscopes also offer economic efficiency due to the reduced risk of cross-infection, lower maintenance costs, and elimination of sterilization activities. Thus, leading companies across the globe are focusing on launching new products that can be used with single-use bronchoscopes. For instance, in May 2024, Olympus America Inc. launched the DVM-B2 Digital Video Monitor, a video processor and monitor that can be used with single-use endoscopes for both ENT and bronchoscopy. Such launches are providing healthcare providers flexibility in selecting their endoscopy solutions and are improving workflow and productivity.

North America Region Holds Major Market Share

The market's growth can be attributed to the increasing investments towards the healthcare sector, strong presence of leading market players, and rising cases of colon cancer, inflammatory bowel disease, gastroesophageal reflux disease, and celiac disease. As per the estimates of the American Cancer Society, approximately 107,320 new cases of colon cancer will be reported in the United States in 2025. Medical professionals often rely on disposable endoscopes for accurate diagnosis of such conditions, propelling the market's demand.

Meanwhile, the market in the Asia-Pacific is expected to witness significant growth in the coming years due to the growing burden of target diseases, rapid expansion of the population, and increasing efforts to bolster the availability of advanced therapeutic and diagnostic solutions in the region. Moreover, the rising efforts towards infection control and reducing the risk of viral transmission are increasing the preference for disposable products, providing lucrative growth opportunities for the market.

Impact of the U.S. Tariff on Global Disposable Endoscopes Market

The recently imposed tariffs on imported medical devices, including disposable endoscopes, are expected to increase costs for healthcare providers and manufacturers, resulting in changes in procurement practices and price adjustments. Some manufacturers are focusing on absorbing costs, while others are working on sourcing materials domestically and shifting production, impacting their profitability. The cumulative effect of tariffs may lead to increased costs for disposable endoscopes, affecting both healthcare providers and manufacturers. Various manufacturers are also working on adjusting their supply chains to avoid tariffs, potentially leading to changes in manufacturing and sourcing locations.

Key Players Landscape and Outlook

The key players of the market are focusing on launching new products and technologies to enhance user convenience. For instance, in April 2024, Olympus Corporation received US FDA 510(k) clearance for RenaFlex, its first single use ureteroscope system. The system is used for visualizing and accessing urinary tracts for diagnosing and treating urinary diseases and disorders, including kidney stones. The system visualizes canals, cavities, and organs in the urinary tract via percutaneous or transurethral access routes. Such innovations are addressing the different concerns associated with device reprocessing and cross contamination. Additionally, such launches are allowing the key players of the market to diversify their revenue streams and strengthen their position in the industry.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of the U.S. Tariffs

4. Executive Summary

5. Global Disposable Endoscopes Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Device Type
    • 5.2.1.1. Flexible Endoscopes
    • 5.2.1.2. Rigid Endoscopes
  • 5.2.2. By Application
    • 5.2.2.1. Bronchoscopy
    • 5.2.2.2. Gastrointestinal (GI) Endoscopy
    • 5.2.2.3. ENT Endoscopy
    • 5.2.2.4. Urologic Endoscopy
    • 5.2.2.5. Arthroscopy
    • 5.2.2.6. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Ambulatory Surgical Centers (ASCs)
    • 5.2.3.3. Diagnostic Centers
    • 5.2.3.4. Specialty Clinics
  • 5.2.4. By Region
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia-Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East and Africa
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Device Type
  • 5.3.2. By Application
  • 5.3.3. By End-user
  • 5.3.4. By Region

6. North America Disposable Endoscopes Market Outlook, 2018-2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
  • 6.1.2. By Volume
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Device Type
    • 6.2.1.1. Flexible Endoscopes
    • 6.2.1.2. Rigid Endoscopes
  • 6.2.2. By Application
    • 6.2.2.1. Bronchoscopy
    • 6.2.2.2. Gastrointestinal (GI) Endoscopy
    • 6.2.2.3. ENT Endoscopy
    • 6.2.2.4. Urologic Endoscopy
    • 6.2.2.5. Arthroscopy
    • 6.2.2.6. Others
  • 6.2.3. By End-user
    • 6.2.3.1. Hospitals
    • 6.2.3.2. Ambulatory Surgical Centers (ASCs)
    • 6.2.3.3. Diagnostic Centers
    • 6.2.3.4. Specialty Clinics
  • 6.2.4. By Country Share
    • 6.2.4.1. United States
    • 6.2.4.2. Canada
    • 6.2.4.3. Mexico
• 6.3. Country Market Assessment
  • 6.3.1. United States Disposable Endoscopes Market Outlook, 2018-2032F*
    • 6.3.1.1. Market Size Analysis & Forecast
      • 6.3.1.1.1. By Value
      • 6.3.1.1.2. By Volume
    • 6.3.1.2. Market Share Analysis & Forecast
      • 6.3.1.2.1. By Device Type
        • 6.3.1.2.1.1. Flexible Endoscopes
        • 6.3.1.2.1.2. Rigid Endoscopes
      • 6.3.1.2.2. By Application
        • 6.3.1.2.2.1. Bronchoscopy
        • 6.3.1.2.2.2. Gastrointestinal (GI) Endoscopy
        • 6.3.1.2.2.3. ENT Endoscopy
        • 6.3.1.2.2.4. Urologic Endoscopy
        • 6.3.1.2.2.5. Arthroscopy
        • 6.3.1.2.2.6. Others
      • 6.3.1.2.3. By End-user
        • 6.3.1.2.3.1. Hospitals
        • 6.3.1.2.3.2. Ambulatory Surgical Centers (ASCs)
        • 6.3.1.2.3.3. Diagnostic Centers
        • 6.3.1.2.3.4. Specialty Clinics
  • 6.3.2. Canada
  • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Disposable Endoscopes Market Outlook, 2018-2032F

• 7.1. Germany
• 7.2. France
• 7.3. Italy
• 7.4. United Kingdom
• 7.5. Russia
• 7.6. Netherlands
• 7.7. Spain
• 7.8. Turkey
• 7.9. Poland

8. Asia-Pacific Disposable Endoscopes Market Outlook, 2018-2032F

• 8.1. India
• 8.2. China
• 8.3. Japan
• 8.4. Australia
• 8.5. Vietnam
• 8.6. South Korea
• 8.7. Indonesia
• 8.8. Philippines

9. South America Disposable Endoscopes Market Outlook, 2018-2032F

• 9.1. Brazil
• 9.2. Argentina

10. Middle East and Africa Disposable Endoscopes Market Outlook, 2018-2032F

• 10.1. Saudi Arabia
• 10.2. UAE
• 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

• 17.1. Market Drivers
• 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Framework

• 19.1. Regulatory Approvals

20. Patent Landscape

21. Case Studies

22. Competitive Landscape

• 22.1. Competition Matrix of Top 5 Market Leaders
• 22.2. SWOT Analysis for Top 5 Players
• 22.3. Key Players Landscape for Top 10 Market Players
  • 22.3.1. Ambu A/S
    • 22.3.1.1. Company Details
    • 22.3.1.2. Key Management Personnel
    • 22.3.1.3. Products and Services
    • 22.3.1.4. Financials (As Reported)
    • 22.3.1.5. Key Market Focus and Geographical Presence
    • 22.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 22.3.2. Boston Scientific Corporation
  • 22.3.3. FUJIFILM Holdings America Corporation
  • 22.3.4. Olympus Corporation
  • 22.3.5. KARL STORZ SE & Co. KG
  • 22.3.6. Hoya Corporation (PENTAX Medical)
  • 22.3.7. Verathon Inc.
  • 22.3.8. CooperSurgical, Inc.
  • 22.3.9. Hill-Rom Holdings, Inc.
  • 22.3.10. Flexicare (Group) Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

23. Strategic Recommendations

24. About Us and Disclaimer